DOT drug testsordered in minutes.MRO‑reviewed.

Any CDL driver operating a commercial motor vehicle (CMV) in a safety‑sensitive function for an FMCSA‑regulated carrier must be enrolled in a DOT‑compliant drug and alcohol testing program. This includes owner‑operators who drive their own trucks. Safety‑sensitive functions include driving, loading and securing cargo, fueling, inspecting, or repairing a CMV.

The DOT‑mandated 5‑panel urine test screens the five substance categories set by the Department of Health and Human Services, listed with their cutoff concentrations at 49 CFR § 40.85. The panel was last widened by the 2017 HHS Mandatory Guidelines, which added a further group of prescription medications to it. Specimen collection and chain‑of‑custody procedures follow strict HHS/SAMHSA standards, and every result is reviewed by a DOT‑qualified Medical Review Officer (MRO) — who contacts the donor about any valid prescription — before anything is reported to the employer.

A positive result triggers a DOT‑defined return‑to‑duty process. The driver must be immediately removed from all safety‑sensitive functions. They must be evaluated by a DOT‑qualified Substance Abuse Professional (SAP), complete the SAP‑recommended education or treatment, pass a return‑to‑duty drug test with a verified negative, and complete a follow‑up testing schedule — minimum 6 unannounced tests in the first 12 months. The violation is also reported to the FMCSA Clearinghouse. We coordinate the entire RTD process and track follow‑up tests.

A return‑to‑duty test can only happen after the driver’s Substance Abuse Professional (SAP) has reported them eligible for it in the FMCSA Clearinghouse; a test taken earlier does not count. Follow‑up tests follow the SAP’s written plan. Both are collected under direct observation by a collector of the same sex, and the test type (drug, alcohol, or both) is whatever the SAP’s report calls for. The employer reports the negative return‑to‑duty result, and later the completed follow‑up plan, to the Clearinghouse. We do that for you, so before ordering, designate Trucking Comply LLC as your C/TPA in your company’s Clearinghouse account; we can’t process the order without it. Owner‑operators are required to designate a C/TPA, and a driver with no current employer can register as an owner‑operator and designate us for the return‑to‑duty process.

Every company gets its own account with our lab network, which takes about 5 to 7 business days to set up. If you order before yours is ready, we book the test through Trucking Comply’s lab account at a location in your company’s name, so your company is still named as the employer on the custody form and results go to the contact you choose. The scheduling link can take a little longer while we set that up.

Lab results are routed first to the DOT‑qualified Medical Review Officer (MRO) for verification. The MRO contacts the donor on positives to confirm any prescription explanations. Once the result is finalized, we push it to you electronically as a PDF — ready to drop into the Driver Qualification file. Result timing depends on the lab and the MRO process, both of which sit outside our control; we surface the result the moment it’s available.

No. Our individual drug test ordering service is used to order specific tests — pre‑employment, post‑accident, reasonable suspicion, RTD, or follow‑up. For the mandatory random testing program under 49 CFR Part 382, you must be enrolled in a DOT random testing consortium. Trucking Comply offers a separate DOT Random Testing Consortium membership that covers random selections, MRO fees, policy, and annual MIS filing. Individual drug test orders supplement but do not replace consortium enrollment.

No. Non‑DOT tests do not follow 49 CFR Part 40 procedures, are not conducted at HHS‑certified sites, and are not reviewed by a certified MRO. They cannot be used to satisfy any FMCSA drug testing requirement, including pre‑employment, post‑accident, or random. Using a non‑DOT test when a DOT test is required is itself a violation.

Chain‑of‑custody (COC) is the documented process that tracks a urine specimen from the moment of collection to final MRO review. Under 49 CFR Part 40, every DOT test requires a federal CCF (Custody and Control Form) to document collection, splits, shipping, lab receipt, and MRO review. Breaks in the COC chain can invalidate a test result, create compliance gaps, and expose you to audit findings. Our process ensures a proper electronic CCF is generated for every test.

Yes. FMCSA regulations require a verified negative pre‑employment drug test result before a CDL driver operates a CMV for your company. There is one exception: if the driver is enrolled in a DOT random testing program administered by another employer, and you receive written documentation of that enrollment, and the driver has not had a gap in DOT‑regulated employment greater than 30 days — then you may request a previous employer verification in lieu of a new test. In most practical hiring scenarios, a new pre‑employment test is the safest and cleanest path.